Published in Int J Antimicrob Agents on December 27, 2008
Synthesis and characterization of silver/montmorillonite/chitosan bionanocomposites by chemical reduction method and their antibacterial activity. Int J Nanomedicine (2011) 1.20
Controlling hospital-acquired infection: focus on the role of the environment and new technologies for decontamination. Clin Microbiol Rev (2014) 1.15
Hospital cleaning in the 21st century. Eur J Clin Microbiol Infect Dis (2011) 1.11
Antimicrobial effect of medical textiles containing bioactive fibres. Eur J Clin Microbiol Infect Dis (2010) 0.91
Photodynamic antimicrobial polymers for infection control. PLoS One (2014) 0.84
Re: A novel bactericidal fabric coating with potent in vitro activity against meticillin-resistant Staphylococcus aureus (MRSA). Int J Antimicrob Agents (2009) 0.75
Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis (2003) 13.83
Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance. Proc Natl Acad Sci U S A (2004) 8.95
How clonal is Staphylococcus aureus? J Bacteriol (2003) 7.97
Rapid whole-genome sequencing for investigation of a neonatal MRSA outbreak. N Engl J Med (2012) 6.36
Evolutionary models of the emergence of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2003) 5.29
Global distribution of Panton-Valentine leukocidin--positive methicillin-resistant Staphylococcus aureus, 2006. Emerg Infect Dis (2007) 3.98
Evolution of Staphylococcus aureus by large chromosomal replacements. J Bacteriol (2004) 3.33
Re-emergence of early pandemic Staphylococcus aureus as a community-acquired meticillin-resistant clone. Lancet (2005) 2.99
Seven novel variants of the staphylococcal chromosomal cassette mec in methicillin-resistant Staphylococcus aureus isolates from Ireland. Antimicrob Agents Chemother (2005) 2.87
Determining the genetic structure of the natural population of Staphylococcus aureus: a comparison of multilocus sequence typing with pulsed-field gel electrophoresis, randomly amplified polymorphic DNA analysis, and phage typing. J Clin Microbiol (2002) 2.65
A genomic portrait of the emergence, evolution, and global spread of a methicillin-resistant Staphylococcus aureus pandemic. Genome Res (2013) 2.59
Analyses of clonality and the evolution of bacterial pathogens. Curr Opin Microbiol (2004) 2.47
A population-based study of the incidence and molecular epidemiology of methicillin-resistant Staphylococcus aureus disease in San Francisco, 2004-2005. Clin Infect Dis (2008) 2.35
Related clones containing SCCmec type IV predominate among clinically significant Staphylococcus epidermidis isolates. Antimicrob Agents Chemother (2003) 2.23
Evaluation of molecular typing methods in characterizing a European collection of epidemic methicillin-resistant Staphylococcus aureus strains: the HARMONY collection. J Clin Microbiol (2007) 1.85
Vancomycin susceptibility within methicillin-resistant Staphylococcus aureus lineages. Emerg Infect Dis (2004) 1.84
Molecular tracing of the emergence, adaptation, and transmission of hospital-associated methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci U S A (2012) 1.83
Stability of serotypes during nasopharyngeal carriage of Streptococcus pneumoniae. J Clin Microbiol (2003) 1.78
Improved multilocus sequence typing scheme for Staphylococcus epidermidis. J Clin Microbiol (2006) 1.77
Population structure of a hybrid clonal group of methicillin-resistant Staphylococcus aureus, ST239-MRSA-III. PLoS One (2010) 1.64
Detection of new methicillin-resistant Staphylococcus aureus clones containing the toxic shock syndrome toxin 1 gene responsible for hospital- and community-acquired infections in France. J Clin Microbiol (2006) 1.46
Diversity of methicillin-resistant Staphylococcus aureus (MRSA) strains isolated from inpatients of 30 hospitals in Orange County, California. PLoS One (2013) 1.37
Genetic background affects stability of mecA in Staphylococcus aureus. J Clin Microbiol (2005) 1.33
Influence of recombination and niche separation on the population genetic structure of the pathogen Streptococcus pyogenes. Infect Immun (2002) 1.31
Molecular genetic typing reveals further insights into the diversity of animal-associated Staphylococcus aureus. J Med Microbiol (2009) 1.29
Evolutionary genetics of the accessory gene regulator (agr) locus in Staphylococcus aureus. J Bacteriol (2005) 1.26
Bacteriophage therapy: potential uses in the control of antibiotic-resistant pathogens. Expert Rev Anti Infect Ther (2011) 1.16
Multilocus sequence typing of Staphylococcus aureus with DNA array technology. J Clin Microbiol (2003) 1.13
Diversity of methicillin-resistant Staphylococcus aureus strains isolated from residents of 26 nursing homes in Orange County, California. J Clin Microbiol (2013) 1.12
Amoebae promote persistence of epidemic strains of MRSA. Environ Microbiol (2006) 1.06
The role of regulated clinical trials in the development of bacteriophage therapeutics. J Mol Genet Med (2012) 1.01
Differences in methicillin-resistant Staphylococcus aureus strains isolated from pediatric and adult patients from hospitals in a large county in California. J Clin Microbiol (2012) 0.97
Genetic analysis of Staphylococcus aureus from intravenous drug user lesions. J Med Microbiol (2004) 0.91
Clinical and Microbiological Determinants of Outcome in Staphylococcus aureus Bacteraemia. Int J Microbiol (2010) 0.91
Predicting high prevalence of community methicillin-resistant Staphylococcus aureus strains in nursing homes. Infect Control Hosp Epidemiol (2013) 0.90
Retraction. Science (2002) 0.82
Predictors of hospitals with endemic community-associated methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol (2013) 0.80
Multilocus sequence typing scheme for Staphylococcus aureus: revision of the gmk locus. J Clin Microbiol (2012) 0.79
In vitro activity of a novel compound, the metal ion chelating agent AQ+, against clinical isolates of Staphylococcus aureus. J Antimicrob Chemother (2005) 0.78
Enhancement of the antimicrobial properties of bacteriophage-K via stabilization using oil-in-water nano-emulsions. Biotechnol Prog (2014) 0.78